Z-1506-2025 Class II Ongoing

Recalled by Medtronic Neuromodulation — Minneapolis, MN

FDA device recall Z-1506-2025 was initiated by Medtronic Neuromodulation on January 9, 2025 and is designated Class II. Reason for recall: Product complaints were received describing the A820 myPTM app taking longer than expected for patients to interact with their implantable pump. The recall status is ongoing. Affected quantity: 4365 units.

Recall Details

Product Type
Devices
Report Date
April 9, 2025
Initiation Date
January 9, 2025
Termination Date
N/A
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
4365 units

Product Description

A820 myPTM Software Application associated with Medtronic SynchroMed Pump and Infusion System.

Reason for Recall

Product complaints were received describing the A820 myPTM app taking longer than expected for patients to interact with their implantable pump.

Distribution Pattern

Worldwide distribution - US Nationwide and the countries of Austria, Belgium, Canary Islands, Czech Republic, France, Germany, Greece, Ireland, Italy, Netherlands, Norway, Portugal, Puerto Rico, Spain, Sweden, Switzerland, United Kingdom.

Code Information

version v.2x, UDI/DI 00763000632793